Evidence map›Paper›PMID 37959172›Full record

ArticleJournal of clinical medicine2023

Phenotypic Clustering of Beta-Thalassemia Intermedia Patients Using Cardiovascular Magnetic Resonance.

Antonella Meloni, Michela Parravano, Laura Pistoia, Alberto Cossu, Emanuele Grassedonio, Stefania Renne, Priscilla Fina, Anna Spasiano, Alessandra Salvo, Sergio Bagnato and 4 more

Abstract read
In one paragraph

Article in Journal of clinical medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Antonella MeloniDepartment of Radiology, Fondazione G. Monasterio CNR-Regione Toscana, 56124 Pisa, PI, Italy.ORCID 0000-0002-2284-8585
Michela ParravanoUnità Operativa Complessa Bioingegneria, Fondazione G. Monasterio CNR-Regione Toscana, 56124 Pisa, PI, Italy.ORCID 0009-0001-1964-9948
Laura PistoiaDepartment of Radiology, Fondazione G. Monasterio CNR-Regione Toscana, 56124 Pisa, PI, Italy.ORCID 0000-0002-5319-2769
Alberto CossuUnità Operativa Radiologia Universitaria, Azienda Ospedaliero-Universitaria "S. Anna", 44124 Cona, FE, Italy.ORCID 0000-0002-3462-1695
Emanuele GrassedonioSezione di Scienze Radiologiche, Dipartimento di Biopatologia e Biotecnologie Mediche, Policlinico "Paolo Giaccone", 90127 Palermo, PA, Italy.ORCID 0000-0002-2113-7300
Stefania RenneStruttura Complessa di Cardioradiologia-UTIC, Presidio Ospedaliero "Giovanni Paolo II", 88046 Lamezia Terme, CZ, Italy.
Priscilla FinaUnità Operativa Complessa Diagnostica per Immagini, Ospedale "Sandro Pertini", 00157 Roma, RM, Italy.
Anna SpasianoUnità Operativa Semplice Dipartimentale Malattie Rare del Globulo Rosso, Azienda Ospedaliera di Rilievo Nazionale "A. Cardarelli", 80131 Napoli, NA, Italy.
Alessandra SalvoUnità Operativa Semplice Talassemia, Presidio Ospedaliero "Umberto I", 96100 Siracusa, SR, Italy.
Sergio BagnatoEmatologia Microcitemia, Ospedale San Giovanni di Dio-ASP Crotone, 88900 Crotone, KR, Italy.
Calogera GerardiUnità Operativa Semplice Dipartimentale di Talassemia, Presidio Ospedaliero "Giovanni Paolo II"-Distretto AG2 di Sciacca, 92019 Sciacca, AG, Italy.
Zelia BorsellinoUnità Operativa Complessa Ematologia con Talassemia, ARNAS Civico "Benfratelli-Di Cristina", 90134 Palermo, PA, Italy.
Filippo CademartiriDepartment of Radiology, Fondazione G. Monasterio CNR-Regione Toscana, 56124 Pisa, PI, Italy.ORCID 0000-0002-0579-3279
Vincenzo PositanoDepartment of Radiology, Fondazione G. Monasterio CNR-Regione Toscana, 56124 Pisa, PI, Italy.ORCID 0000-0001-6955-9572

Funding

Chiesi (Italy) NA
6 · The paper itself

Abstract

We employed an unsupervised clustering method that integrated demographic, clinical, and cardiac magnetic resonance (CMR) data to identify distinct phenogroups (PGs) of patients with beta-thalassemia intermedia (β-TI). We considered 138 β-TI patients consecutively enrolled in the Myocardial Iron Overload in Thalassemia (MIOT) Network who underwent MR for the quantification of hepatic and cardiac iron overload (T2* technique), the assessment of biventricular size and function and atrial dimensions (cine images), and the detection of replacement myocardial fibrosis (late gadolinium enhancement technique). Three mutually exclusive phenogroups were identified based on unsupervised hierarchical clustering of principal components: PG1, women; PG2, patients with replacement myocardial fibrosis, increased biventricular volumes and masses, and lower left ventricular ejection fraction; and PG3, men without replacement myocardial fibrosis, but with increased biventricular volumes and masses and lower left ventricular ejection fraction. The hematochemical parameters and the hepatic and cardiac iron levels did not contribute to the PG definition. PG2 exhibited a significantly higher risk of future cardiovascular events (heart failure, arrhythmias, and pulmonary hypertension) than PG1 (hazard ratio-HR = 10.5;

Indexed as

cardiovascular magnetic resonance imagingclusteringphenomappingthalassemia intermedia

Identifiers

PMID37959172
PMCPMC10647397

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.